- Marketwired•2 hours ago
Kane Biotech Inc. announced that on September 28, 2016, it issued 256,600 common shares of the Corporation in payment of $12,830 in interest owing on the Corporation's $500,000 2 year 10% convertible redeemable ...
- Marketwired•3 months ago
Kane Biotech Inc. today announced that the global animal health company with which it had a Joint Development Agreement , previously announced by Kane Biotech on May 13, 2015, has made a business decision ...
- Marketwired•3 months agoKane Biotech Announces Closing of Private Placement Offering and Issuance of Common Shares in Payment of Outstanding Interest
Kane Biotech Inc. today announced that the Corporation has closed its previously announced private placement offering of common shares at a price of $0.03 per Common Share. At the closing, the Corporation ...
Kane Biotech Inc. (KNE.V)
TSXV - TSXV Delayed Price. Currency in CAD
|Day's Range||0.02 - 0.03|
|52wk Range||0.02 - 0.08|
|1y Target Est||N/A|
|P/E Ratio (ttm)||-1.39|
|Avg Vol (3m)||120,820|
|Dividend & Yield||N/A (N/A)|